Dr Gonzalo Tapia Rico is committed to achieving the best possible outcomes for his patients. He prides himself in building strong, lasting relationships with his patients and their loved ones, supporting them every step of the way.
Biography
Dr Gonzalo Tapia Rico is an experienced medical oncologist at Icon Cancer Centre Adelaide and Icon Cancer Centre Windsor Gardens. He undertook medical training at the Complutense University of Madrid and completed medical oncology training at one of Spain’s most prestigious hospitals, Gregorio Marañón Hospital. In 2013 he received his PhD degree for research exploring alternative classifications of molecular subtypes in breast cancer.
Dr Tapia Rico subsequently worked as a medical oncologist in the United Kingdom at the Royal Infirmary and Western General Hospitals in Edinburgh and Addenbrooke’s Hospital in Cambridge. He moved to Australia in 2016. As medical oncology clinical research fellow at both The Queen Elizabeth Hospital and Royal Adelaide Hospital, he gained extensive knowledge and experience in all aspects of cancer clinical trials, with the overarching desire to make meaningful improvements to patient outcomes.
He maintains a strong interest in education, clinical trials and research in both his private practice and roles as Clinical Senior Lecturer at the University of Adelaide and Clinical Director of Education at Icon Cancer Centre Adelaide. He has published numerous peer-reviewed articles in leading publications such as Cancer Treatment Reviews and Critical Reviews in Oncology/Haematology. Dr Tapia Rico is a fellow of the Royal Australasian College of Physicians (FRACP) and a member of several leading Australian and international cancer research institutions.
Dr Tapia Rico speaks fluent English and Spanish, and looks forward to caring for patients and their loved ones in their preferred language. His clinical experience covers a broad range of solid tumour malignancies, with a special clinical interest in immunotherapy, melanoma, gastrointestinal cancer, lung cancer, thyroid cancer and breast cancer.